Acellular pertussis vaccine efficacy: An updated systematic review and meta-analysis

Medical Journal of the Islamic Republic of Iran

Volumn 30, Issue 1, 2016, Pages

  Mansour Ghanaei, Roxana ^a   Moradi Lakeh, Maziar ^b   Shakerian, Sareh ^c   Karimi, Abdollah ^a   Esmaeeli, Shooka ^d   Shokraneh, Farhad ^e   Mahmoudi, Susan ^f   Yaghoubi, Mohsen ^g  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^f MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^g IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acellular vaccine; Whole cell vaccine; Whooping cough

Indexed keywords

EID: 85019018004     PISSN: 10161430     EISSN: 22516840     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology, 5th ed. Elsevier Mosby, Philadelphia, PA 2005
2. Sato Y, Kimura M, Fukumi H. Development of a pertussis component vaccine in Japan. Lancet 1984;1(8369):122-6
3. Lankinen K, editor. EUVAX project report. Scientific and technical evaluation of vaccination programmes in the European Union. Brussels: Commission of the European Communities; 2001
4. Marzouqi I, Richmond P, Fry S, Wetherall J, Mukkur T. Development of improved vaccines against whooping cough: Current status. Human Vaccines 2010;6(7):543-553
5. Technical advisory group on vaccinepreventable diseases XX meeting "Paving the way for immnuzation "Washington DC, 17-19 October 2012 Final report, Available online at: http:// www.paho.org/immunization/toolkit/resources/techrecommendations/ TAG-2012.pdf?ua=1
6. Hitchcock WP. Rationale for use of Tdap booster vaccines for adolescent immunization: Overview of efficacy, safety, and clinical use.Clinical Pediatrics 2006;45(9):785-794
7. Zhang L, Prietsch SOM, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database of Systematic Reviews 2012;3
8. Centre for Reviews and Dissemination. CRD search strategies for identifying systematic reviews and meta-analysis on MEDLINE. [Accessed January 12, 2011]. Available from: http:// www.york.ac.uk/inst/crd/intertasc/
9. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www. cochrane-handbook.org
10. EBSCOhost. What are the search strategies used by CINAHL Clinical Queries? [Accessed August 18, 2012]. Available from: http:// support. epnet.com/knowledge_base/detail.php?id=4005
11. US National Library of Medicine. Search Strategy Used to Create the Systematic Reviews Subset on PubMed. [Accessed August 18, 2012]. Available from: http://www.nlm.nih.gov/bsd/ pubmed_ subsets/sysreviews_strategy.html
12. Lee E, Dobbins M, DeCorby K, McRae L, Tirilis D, Husson H. An optimal search filter for retrieving systematic reviews and meta-analyses. BMC Medical Research Methodology 2012;12:51
13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of internal medicine 2009;151(4):W-65
14. Systematic Review Appraisal Sheet. Centre for Evidence Based Medicine. University of Oxford [http://www.cebm.net/index.aspx?o=1567]
15. Singh J. Critical appraisal skills programme. Journal of Pharmacology and Pharmacotherapeutics 2013 Jan 1;4(1):76
16. Geoffrey A. Weinberg and Peter G. Szilagyi. Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap. J Infect Dis 2010;201(11):1607-1610
17. Withdrawn TO. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2008;(2):CD001478
18. Rodríguez-Coboa I, Chen YF, Olowokure B, Litchfield I. Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review. Vaccine 2008 Dec 9;26(52):6768-76
19. Johns TL. New combination vaccines: DTaPIPV (kinrix) and DTaP-IPV/Hib (pentacel). Ann Pharmacother 2010 Mar;44(3):515-23
20. Plosker GL. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix)+: A review of its use as a singledose booster immunization in individuals aged 1064 years in the US. BioDrugs 2009;23(4):253-67
21. Carvalho AP. Acellular pertussis vaccine for adolescents. J Pediatr 2006 Jul;82(3 Suppl): S15-24
22. Jefferson T. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003 May;21(17-18):2003-14
23. Wintermeyer SM. Whole-cell and acellular pertussis vaccines. The Annals of Pharmacotherapy 1994;28(7-8):925-939
24. Gil A. Acellular pertussis vaccine: Metaanalysis 1996
25. Tinnion O. Acellular vaccines prevent pertussis as effectively as whole-cell vaccines with fewer adverse events .Cochrane Review, latest version 24 Feb 1999. InCochrane Library. Oxford: Update Software
26. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a twocomponent acellular, a five-component acellular, and a whole-cell pertussis vaccine. New England Journal of Medicine 1996;334(6):349-55
27. Trollfors B, Taranger J, Lagergard T, Lind L, Sundh V, Zackrisson G, et al. A placebo-controlled trial of a pertussistoxoid vaccine. New England Journal of Medicine 1995;333(16):1045-50
28. Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, et al. Progetto Pertosse Working Group. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. New England Journal of Medicine 1996; 334(6):341-8
29. Heijbel H, Rasmussen F, Olin P. Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II. Developments in Biological Standardization 1997;89:99-100
30. Heijbel H, Ciofi degli Atti MC, Harzer E, Liese J, Preziosi MP, Rasmussen F, et al. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies. Developments in Biological Standardization 1997;89:101-3
31. Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. New England Journal of Medicine 2005;353(15):1555-63
32. Salmaso S. Sustained Efficacy during the First 6 Years of Life of 3-Component Acellular Pertussis Vaccines Administered in Infancy: The Italian Experience. PEDIATRICS 2001;108(5)
33. De Serres G, Shadmani R, Boulianne N, Duval B, Rochette L, Fradet MD, et al. Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine. Vaccine 2001;19(20):3004-8
34. González MF, Moreno CA, Amela HC, Pachón DA, García Del BA, Herrero CC, et al. A study of whooping cough epidemic outbreak in Castellón, Spain. Rev ESP Salud Publica 2002;76(4): 311-9
35. Iskedjian M, Walker JH, De SG, Einarson TR. Economic evaluation of extended acellular pertussis vaccine programfor adolescents in Quebec, Canada. Paediatr Drugs 2005;7(2):123-36
36. Stevenson M, Beard S, Finn A, Brennan A. Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule. Vaccine 2002;20(13-14):1778-86
37. Edmunds WJ, Brisson M, Melegaro A, Gay NJ. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine 2002;20(9):1316-30
38. Caro JJ, Getsios D, El-Hadi W, Payne K, O'Brien JA. Pertussis immunization of adolescents in the United States: an economic evaluation. Pediatr Infect Dis J 2005;24(5 Suppl):S75-82
39. Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA, et al. Pertussis in adolescents and adults: should we vaccinate? Pediatrics 2005; 115(6):1675-84
40. Simondon F, Preziosi MP, Yam A, Kane CT, Chabirand L, Iteman I, et al. A randomized doubleblind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997 Oct;15(15):1606-12
41. Olin P. Randomised controlled trial of twocomponent, three-component, and five-component acellular pertussis vaccines compared with wholecell pertussis vaccine. Lancet 1997;350:1569-77
42. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011;204: 334.e1-5
43. Littmann M, Hülße C, Riffelmann M, von König CH. Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric healthcare workers. Vaccine 2008 2;26(19):2344-9
44. Updated WHO position paper on pertussis vaccines. Geneva, Switzerland. October 2010. Available at: http://www.who.int/immunization/ Pertussis_position_paper_slides_oct2010.pdf
45. Sandora TJ, Gidengil CA, Lee GM. Pertussis Vaccination for Health Care Workers. Clin Microbiol Rev Jul 2008;21(3):426-434